MergerLinks - Peter Kolchinsky

PrivateAcquisitionMinorityPrivate EquityVenture CapitalDomestic

target

Legend Biotech Corporation

bidder

Lilly Asia Ventures

£121m

13 dealmakers

China

AcquisitionPrivate EquityPrivateMinorityVenture CapitalCross Border

target

Everest Medicines

bidder

Octagon Investments

£245m

18 dealmakers

MinorityPublicPrivate EquityAcquisitionDomestic

target

NOVAVAX

bidder

Ra Capital Management

£159m

17 dealmakers

Private EquityMinorityAcquisitionPublicReverse TakeoverDomesticDe-SPAC

target

Cerevel Therapeutics

bidder

Ecor1 Capital

£1,002m

66 dealmakers

PrivateMinorityPrivate EquityAcquisitionVenture Capital

target

Kinnate Biopharma

bidder

Nextech Invest

£74m

9 dealmakers

China

PrivateMinorityCross BorderAcquisitionVenture CapitalPrivate Equity

target

LIANBIO

bidder

Logos Capital

£239m

18 dealmakers

Denmark

MinorityAcquisitionVenture CapitalPrivatePrivate EquityCross Border

target

Io Biotech

bidder

Lundbeckfonden Emerge

£113m

16 dealmakers

PrivateMinorityVenture CapitalDomesticPrivate EquityAcquisition

target

Tscan Therapeutics

bidder

6 Dimensions Capital

£73m

11 dealmakers

Private EquityDomesticMergerMajorityPrivateReverse TakeoverDe-SPAC

target

Nautilus Biotechnology

bidder

Arya Sciences Acquisition Corp Iii

£654m

44 dealmakers

DomesticVenture CapitalPrivatePrivate EquityMinorityAcquisition

target

Artiva Biotherapeutics

bidder

Acuta Capital

value n/a

16 dealmakers

PrivateVenture CapitalPrivate EquityMinorityAcquisitionCross Border

target

Century Therapeutics

bidder

Fidelity Management & Research Company

£115m

24 dealmakers

Cross BorderPrivate EquityAcquisitionPrivateMinorityVenture Capital

Medical Services

target

Icosavax

bidder

Sanofi Ventures

£71m

19 dealmakers

Ireland

MinorityCross BorderPrivate EquityAcquisitionVenture CapitalPrivate

target

Gh Research

bidder

Deerfield Management Company

£91m

20 dealmakers

MinorityPrivatePrivate EquityCross BorderVenture CapitalAcquisition

target

Affinia Therapeutics

bidder

Casdin Capital

£80m

15 dealmakers

AcquisitionPrivateDomesticMinorityPrivate EquityVenture Capital

target

Nikang Therapeutics

bidder

Surveyor Capital

£141m

29 dealmakers

AcquisitionPrivateMinorityVenture CapitalPrivate EquityDomestic

target

SYNTHEKINE

bidder

Janus Henderson Investors

£75m

13 dealmakers

PrivateCross BorderMinorityVenture CapitalAcquisitionPrivate Equity

target

Element Biosciences

bidder

Counterpoint Global - Morgan Stanley

£198m

12 dealmakers

MajorityMergerDe-SPACPrivate EquityDomesticPrivateAcquisitionReverse Takeover

target

Pardes Biosciences

bidder

Ecor1 Capital

£199m

37 dealmakers

Private EquityDomesticPrivateVenture CapitalMinorityAcquisition

target

Antios Therapeutics

bidder

Amzak Capital Management

£69m

22 dealmakers

Private EquityMinorityPrivateAcquisitionVenture CapitalDomestic

Medical Equipment

target

EXO

bidder

Pura Vida Investments

£158m

6 dealmakers

Germany

Venture CapitalAcquisitionMinorityPrivate EquityCross BorderPrivate

target

T-KNIFE

bidder

Caas Capital Management

£79m

29 dealmakers

Private EquityPrivateAcquisitionVenture CapitalDomesticMinority

target

GENTIBIO

bidder

Matrix Capital Management

£113m

7 dealmakers

Reverse TakeoverPrivateMergerDe-SPACDomesticMajority

target

Point Biopharma

bidder

Research Alliance Corp I

£419m

9 dealmakers

AcquisitionMinorityPrivate EquityCross BorderPrivateVenture Capital

target

METAGENOMI

bidder

MODERNA

£129m

17 dealmakers

Venture CapitalCross BorderAcquisitionMinorityPrivatePrivate Equity

Health Care Services

target

SOMATUS

bidder

Wellington Management

£238m

14 dealmakers

MinorityPrivate EquityPrivateVenture CapitalDomesticAcquisition

target

Be Bio

bidder

Atlas Venture

£99m

10 dealmakers

AcquisitionVenture CapitalPrivatePrivate EquityDomesticMinority

target

Mbx Biosciences

bidder

Wellington Management

£97m

8 dealmakers

PrivateMinorityPrivate EquityAcquisitionCross BorderVenture Capital

Health Care Services

target

Cg Oncology

bidder

Ally Bridge Group

£101m

12 dealmakers

MinorityAcquisitionDomesticPrivatePrivate EquityVenture Capital

target

VAXESS

bidder

The Engine

£23m

5 dealmakers

AcquisitionPrivate EquityDomesticMinorityPrivate

target

Lenz Therapeutics

bidder

Point72 Ventures

£69m

7 dealmakers

AcquisitionPrivatePrivate EquityDomesticMinorityVenture Capital

target

Carmot Therapeutics

bidder

Deep Track Capital

£120m

18 dealmakers